IP Library › Granted Patent US 9,725,704
Granted Patent B2
US 9,725,704 · App. 14/374,556 · Granted Aug 8, 2017

Expression method

Inventors: Tobias Kueppers (Moenchengladbach, DE); Victoria Steffen (Juelich, DE); Renee Charlott Eichstadt (Cologne, DE); Stefan Evers (Mettmann, DE); Karl-Heinz Maurer (Erkrath, DE); Johannes Bongaerts (Dormagen, DE); Hendrik Hellmuth (Duesseldorf, DE); Thomas Weber (Dormagen, DE); Timothy O'Connell (Duesseldorf, DE)
Assignee: BASF SE
C12N9/2411C12N9/00C12N9/2414C12N9/50C12N9/54C12N15/75C12P21/02
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,725,704
App. No.
14/374,556
Granted
Aug 8, 2017
Kind
B2
Abstract

In a microbial fermentation, the aim is to increase the product yield of protein. This is achieved by a method in which an expression construct is introduced into a microorganism of the species Bacillus pumilus which comprises a promoter and a nucleic acid coding for the protein, and the protein is expressed in said expression construct.

Claims (35)

1. A method for producing a protein by means of a microorganism comprising

(a) introducing an expression construct into a microorganism which comprises a promoter and a nucleic acid coding for the protein;

(b) expressing the protein in the microorganism,

wherein the microorganism belongs to the species Bacillus pumilus ; and

wherein the microorganism is sporulation-inhibited as a result of deleting the gene spoIV (yqfD) or parts thereof.

2. The method according to claim 1 , wherein the promoter comprises a nucleic acid sequence which is selected from

(a) nucleic acid sequence which is at least 95% identical to the nucleic acid sequence given in SEQ ID No. 1;

(b) nucleic acid sequence which is at least 95% identical to the nucleic acid sequence given in SEQ ID No. 2;

(c) nucleic acid sequence which is at least 95% identical to the nucleic acid sequence given in SEQ ID No. 3; or

(d) nucleic acid sequence which is at least 95% identical to the nucleic acid sequence given in SEQ ID No. 4.

3. The method according to claim 1 , wherein the protein is not naturally present in the microorganism.

4. The method according to claim 1 , wherein the protein is an enzyme.

5. The method according to claim 1 , wherein the microorganism is Bacillus pumilus DSM 14395.

6. The method according to claim 1 , wherein the microorganism is genetically modified.

7. A microorganism obtainable by a method comprising

(a) introducing an expression construct into a microorganism which comprises a promoter and a nucleic acid coding for the protein;

(b) expressing the protein in the microorganism,

wherein the microorganism belongs to the species Bacillus pumilus ; and

wherein the microorganism is sporulation-inhibited as a result of deleting the gene spoIV (yqfD) or parts thereof.

8. The microorganism according to claim 7 , wherein

(a) the promoter comprises a nucleic acid sequence which is selected from

(i) nucleic acid sequence which is at least 95% identical to the nucleic acid sequence given in SEQ ID No. 1;

(ii) nucleic acid sequence which is at least 95% identical to the nucleic acid sequence given in SEQ ID No. 2,

(iii) nucleic acid sequence which is at least 95% identical to the nucleic acid sequence given in SEQ ID No. 3; or

(iv) nucleic acid sequence which is at least 95% identical to the nucleic acid sequence given in SEQ ID No. 4;

or

(b) the protein is not naturally present in the microorganism, or

(c) the protein is an enzyme

or

(d) the microorganism is Bacillus pumilus DSM 14395, or

(e) the microorganism is genetically modified.

9. The method according to claim 4 , wherein the enzyme is an acidic cellulase, alpha-amylase, alpha-acetodecarboxylase, aminopetidase, amylase, arabanase, beta-glucanase, beta-glucosidase, beta-mannosidase, carageenase, carbohydrase, catalase, cellobiose-oxidase, cellulase, chymosin, endo-1,3-beta-glucanase, endo-1,3(4)-beta-glucanase, endo-1,4-beta-xylanase, endopeptidase, esterase, exopeptidase, G4-amylase, glucoamylase, glucose oxidase, glucosidase, glycolipase, hemicellulase, laccase, lipase, lysophospholipase, maltogenic amylase, mannanase, neutral protease, nuclease, oxidase, oxidoreductase, pectate lyase, pectinase, pectin esterase, pentosanase, perhydrolase, phospholipase, phytase, polygalacturonase, protease, proteinase, pullulanase, rennet enzyme, rhamnogalacturonase, subtilisin, tannase, transferase, transglutaminase, xanthanase, xylanase, xyloglucanase or mixtures thereof.

10. The method according to claim 9 , wherein the enzyme is an alpha-amylase, a protease, or a mixture thereof.

11. The method of claim 8 , wherein the enzyme is an acidic cellulase, alpha-amylase, alpha-acetodecarboxylase, aminopetidase, amylase, arabanase, beta-glucanase, beta-glucosidase, beta-mannosidase, carageenase, carbohydrase, catalase, cellobiose-oxidase, cellulase, chymosin, endo-1,3-beta-glucanase, endo-1,3(4)-beta-glucanase, endo-1,4-beta-xylanase, endopeptidase, esterase, exopeptidase, G4-amylase, glucoamylase, glucose oxidase, glucosidase, glycolipase, hemicellulase, laccase, lipase, lysophospholipase, maltogenic amylase, mannanase, neutral protease, nuclease, oxidase, oxidoreductase, pectate lyase, pectinase, pectin esterase, pentosanase, perhydrolase, phospholipase, phytase, polygalacturonase, protease, proteinase, pullulanase, rennet enzyme, rhamnogalacturonase, subtilisin, tannase, transferase, transglutaminase, xanthanase, xylanase, xyloglucanase or mixtures thereof.

12. The method of claim 11 , wherein the enzyme is an alpha-amylase, a protease, or a mixture thereof.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 25, 2014
From: KUEPPERS, TOBIAS; STEFFEN, VICTORIA; EICHSTADT, RENEE CHARLOTT; EVERS, STEFAN; MAURER, KARL-HEINZ; BONGAERTS, JOHANNES; HELLMUTH, HENDRIK; WEBER, THOMAS; O'CONNELL, TIMOTHY
To: BASF SE
Reel/Frame 034263/0808 →
Priority Claims (1)
DE 10 2012 201 297 · Jan 31, 2012 · national
Continuity (1)
Related Publication 20140370569A1 · Dec 18, 2014